Compare RDW & TNDM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | RDW | TNDM |
|---|---|---|
| Founded | 2020 | 2006 |
| Country | United States | United States |
| Employees | 750 | N/A |
| Industry | Military/Government/Technical | Medical/Dental Instruments |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.4B | 1.4B |
| IPO Year | N/A | 2013 |
| Metric | RDW | TNDM |
|---|---|---|
| Price | $9.27 | $23.97 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 7 | 19 |
| Target Price | $12.83 | ★ $27.05 |
| AVG Volume (30 Days) | ★ 15.6M | 2.3M |
| Earning Date | 01-01-0001 | 05-19-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $1,014,736,000.00 |
| Revenue This Year | $38.80 | $10.96 |
| Revenue Next Year | $17.95 | $9.33 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | ★ 7.93 |
| 52 Week Low | $4.87 | $10.00 |
| 52 Week High | $22.25 | $29.65 |
| Indicator | RDW | TNDM |
|---|---|---|
| Relative Strength Index (RSI) | 49.91 | 55.13 |
| Support Level | $7.05 | $19.04 |
| Resistance Level | $10.06 | $29.65 |
| Average True Range (ATR) | 0.81 | 1.78 |
| MACD | 0.08 | 0.24 |
| Stochastic Oscillator | 59.83 | 48.99 |
Redwire Corp is engaged in mission-critical space solutions and reliable components for the next-generation space economy. It assists its customers in solving the complex challenges of future space missions and industries. The company's space infrastructure offerings include a broad array of modern products and services, which have been enabling space missions. The company's plan enables it to combine decades of flight heritage with a culture creating new technologies that are the building blocks of space infrastructure for government and commercial customers.
Tandem Diabetes designs, manufactures, and markets durable insulin pumps for individuals with diabetes. The firm first entered this market in 2012 and has since introduced multiple generations of pumps leading to its current t:slim X2 device. The firm recently launched its smaller Mobi pump and continues to work on Tobi (a tubeless version of Mobi), and the Sigi tubeless patch pump. Nearly three-quarters of total revenue is derived from the US, with the remainder primarily from other developed nations. The pumps themselves generate just over half of total sales, and another one-third is from disposable infusion sets that need to be changed over every 2 to 3 days.